Effects of neoadjuvant chemotherapy on the expression of ER, PR,HER-2 and Ki67 in breast cancer patients
10.7652/jdyxb201804019
- VernacularTitle:新辅助化疗对乳腺癌患者ER、PR、HER-2及Ki67表达的影响
- Author:
Guang-Hui WANG
1
;
Ya-Nan TANG
;
Nan CHEN
;
Hu-Xia WANG
;
Qian QIN
;
Tian-Yu YU
;
Wei SHENG
Author Information
1. 西安交通大学第一附属医院普外科
- Keywords:
breast cancer;
neoadjuvant chemotherapy;
ER;
PR;
HER-2;
Ki67
- From:
Journal of Xi'an Jiaotong University(Medical Sciences)
2018;39(4):542-545,588
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of neoadjuvant chemotherapy on the expression of four molecular markers ER,PR,HER-2 and Ki6 7 ,so as to provide the basis for accurate individualized treatment of breast cancer patients.Methods We enrolled 165 breast cancer patients who underwent radical surgery in the First Affiliated Hospital of Xi'an Jiaotong University from January 1,2013 to December 31,2015.Among them,62 patients received preoperative neoadjuvant chemotherapy (NAC group),and 103 received no adjuvant (control group).We collected all the patients'preoperative and postoperative pathological specimens;we detected the expression levels of ER,PR,HER-2 and Ki67 by immunohistochemical method.Results Compared with that in control group patients,in NAC group the change rate of ER expression was 12.1% (7/58)and 7.8% (8/103) before and after chemotherapy,respectively,with no significant difference (P=0.3 78);the change rate of PR expression was 10.3% (3/58)and 10.7% (11/103),with no significant difference (P=0.227);the change rate of HER-2 expression was 8.6% (5/58)and 22.3 (23/103),with significant difference (P=0.026);the change rate of Ki67 expression was 39.7% (23/58)and 19.4% (20/103),with significant difference (P=0.006).In addition,the effective rate of neoadjuvant chemotherapy for breast cancer patients with high Ki67 expression was 63.8% (30/47), that of neoadjuvant chemotherapy in patients with low Ki6 7 expression was 3 3 .3 % (5/15),with significant differences between the two groups (P=0.038).Conclusion Neoadjuvant chemotherapy can change the status of HER-2 and Ki6 7 in breast cancer patients,in which the high Ki6 7 expression level predicts better effect of chemo-therapy.
